Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Carter

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Plos One|November 27, 2024
Australian Communities That Care (CTC) intervention: Benefit-cost analysis of a community-based youth alcohol prevention initiativeJulie Abimanyi-Ochom, Sithara Wanni Arachchige Dona, Shalika Bohingamu Mudiyanselage, et al.
Nutrients|May 14, 2022
Cost-Benefit and Cost-Utility Analyses to Demonstrate the Potential Value-for-Money of Supermarket Shelf Tags Promoting Healthier Packaged Products in AustraliaJaithri Ananthapavan, Gary Sacks, Liliana Orellana, et al.
BMJ Open|December 30, 2017
Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacyInes Krass, Rob Carter, Bernadette Mitchell, et al.
Sexually Transmitted Diseases|April 9, 2010
Computer reminders for Chlamydia screening in general practice: a randomized controlled trialJennifer Walker, Christopher K Fairley, Sandra M Walker, et al.
Plos One|June 20, 2020
Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) studyJaithri Ananthapavan, Gary Sacks, Vicki Brown, et al.
Lancet (London, England)|August 30, 2011
Changing the future of obesity: science, policy, and actionSteven L Gortmaker, Boyd A Swinburn, David Levy, et al.
Diabetes Research and Clinical Practice|February 4, 2023
Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacyInes Krass, Rob Carter, Bernadette Mitchell, et al.
Addictive Behaviors|August 11, 2020
Intention to drink and alcohol use before 18 years among Australian adolescents: An extended Theory of Planned BehaviorXiang Zhao, Adrian B Kelly, Bosco Rowland, et al.
BMC Health Services Research|December 1, 2023
Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening TrialInes Krass, Michael J Twigg, Bernadette Mitchell, et al.
Trials|February 2, 2013
The Melbourne Diabetes Prevention Study (MDPS): study protocol for a randomized controlled trialNathalie Davis-Lameloise, Andrea Hernan, Edward D Janus, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Plos One|November 27, 2024
Australian Communities That Care (CTC) intervention: Benefit-cost analysis of a community-based youth alcohol prevention initiativeJulie Abimanyi-Ochom, Sithara Wanni Arachchige Dona, Shalika Bohingamu Mudiyanselage, et al.
Nutrients|May 14, 2022
Cost-Benefit and Cost-Utility Analyses to Demonstrate the Potential Value-for-Money of Supermarket Shelf Tags Promoting Healthier Packaged Products in AustraliaJaithri Ananthapavan, Gary Sacks, Liliana Orellana, et al.
BMJ Open|December 30, 2017
Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacyInes Krass, Rob Carter, Bernadette Mitchell, et al.
Sexually Transmitted Diseases|April 9, 2010
Computer reminders for Chlamydia screening in general practice: a randomized controlled trialJennifer Walker, Christopher K Fairley, Sandra M Walker, et al.
Plos One|June 20, 2020
Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) studyJaithri Ananthapavan, Gary Sacks, Vicki Brown, et al.
Lancet (London, England)|August 30, 2011
Changing the future of obesity: science, policy, and actionSteven L Gortmaker, Boyd A Swinburn, David Levy, et al.
Diabetes Research and Clinical Practice|February 4, 2023
Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacyInes Krass, Rob Carter, Bernadette Mitchell, et al.
Addictive Behaviors|August 11, 2020
Intention to drink and alcohol use before 18 years among Australian adolescents: An extended Theory of Planned BehaviorXiang Zhao, Adrian B Kelly, Bosco Rowland, et al.
BMC Health Services Research|December 1, 2023
Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening TrialInes Krass, Michael J Twigg, Bernadette Mitchell, et al.
Trials|February 2, 2013
The Melbourne Diabetes Prevention Study (MDPS): study protocol for a randomized controlled trialNathalie Davis-Lameloise, Andrea Hernan, Edward D Janus, et al.
Pageof 11